Browse 1,572 kidney cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Many kidney cancers are now found by chance, on a scan done for another reason, often while they are still small and curable with surgery. About 9 in 10 are renal cell carcinoma. For advanced kidney cancer, combinations of immunotherapy and targeted drugs have transformed outcomes over the past decade. Trials are testing what comes next when these combinations stop working, and whether extra treatment after surgery can keep the cancer from returning.
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
for
Kidney Disease
Location: East Providence RI, Philadelphia PA, Media PA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06963827
Phase 3, Recruiting
Active & Responsive
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
for
Metastatic Solid Tumors
Location: Nashville TN, Houston TX, Irving TX, San Antonio TX,
Sponsor: Erasca, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07021898
Phase 1, Recruiting
Active & Responsive
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for
Solid Tumor Malignancies
Location: New Haven CT, Fairfax VA, Jacksonville FL, Sarasota FL,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT06994806
Phase 1, Recruiting
Active & Responsive
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
for
Breast Cancer, Endometrial Cancer, Ovarian Cancer,
Location: Boston MA, Fairfax VA, Orlando FL, Cleveland OH,
Sponsor: Terremoto Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07109726
Phase 1, Phase 2, Recruiting
Active & Responsive
Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
for
Solid Tumors, Hematologic Malignancies
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 0+
Code: NCT02457962
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
for
Cancer, Cancer Comorbidities
Location: Flint MI, Houston TX
Sponsor: National Minority Quality Forum
Sex: All
Age: 35+
Code: NCT07461493
Recruiting
Active & Responsive
Efficacy of Point Of Service Testing in MBC
for
Metastatic Cancer, Breast Cancer
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18+
Code: NCT03983577
Recruiting
Active & Responsive
CREATE: Art for Children With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 8 - 13
Code: NCT06342453
Recruiting
Active & Responsive
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
for
Solid Tumor
Location: Dallas TX, Scottsdale AZ, Portland OR, El Segundo CA,
Sponsor: Alyssum Therapeutics
Sex: All
Age: 18+
Code: NCT06234098
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
for
Advanced Solid Tumors
Location: Moncton, Hackensack NJ, Fairfax VA, Kingston, Toronto,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05067283
Phase 1, Recruiting
Active & Responsive
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Boston MA, New York NY, Hackensack NJ,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT05533697
Phase 1, Phase 2, Recruiting
Active & Responsive
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Hartford CT, New York NY, Englewood NJ, Florham Park NJ,
Sponsor: VM Oncology, LLC
Sex: All
Age: 18 - 70+
Code: NCT03556228
Phase 1, Phase 2, Recruiting
Active & Responsive
Activating Cancer Communities Through an Exercise Strategy for Survivors
for
Cancer
Location: Halifax
Sponsor: Nova Scotia Health Authority
Sex: All
Age: 18+
Code: NCT03599843
Recruiting
Active & Responsive
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies